Yes, Scilex Holding Co is a real company. It’s a biopharmaceutical firm specializing in acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain. Key details include:
• Headquarters: 960 San Antonio Road, Palo Alto, CA 94303, USA.
• Founded/Listed: Publicly traded on Nasdaq under the ticker SCLX since November 11, 2022.
• Products: Their commercial product is ZTlido (lidocaine topical system) for postherpetic neuralgia. They’re also advancing candidates like SEMDEXA (SP-102), a triple-strength ZTlido (SP-103), and SP-104 (low-dose naltrexone).
• Employees: Approximately 31.
• Website: scilexholding.com.
This information is based on current financial market data as of November 2025.